insights_auto
Kwa nini NOVOB80 imeongezeka kwa 2.33%?
Fahamu zaidichevron_right
NOVOB80:BKK
NOVOB80 KTB DR
฿ 1.32
arrow_upward
+2.33%(+0.030) Siku 1
16 Okt, 02:55:30 GMT +7 · THB
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOVOB80...
Fungua
฿ 1.28
Juu
฿ 1.30
Chini
฿ 1.27
Mtaji wa soko
132.50B
Wastani wa kiasi cha mauzo
3.88M
Kiasi cha mauzo ya hisa
4.35M
Juu kwa wiki 52
฿ 2.02
Chini kwa wiki 52
฿ 1.12
Hisa za wawekezaji
3.00B
Idadi ya wafanyakazi
elfu 67
Fungua
฿ 1.28
Juu
฿ 1.30
Chini
฿ 1.27
Mtaji wa soko
132.50B
Wastani wa kiasi cha mauzo
3.88M
Kiasi cha mauzo ya hisa
4.35M
Juu kwa wiki 52
฿ 2.02
Chini kwa wiki 52
฿ 1.12
Hisa za wawekezaji
3.00B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
saa 9 zilizopita
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Traders Union
·
saa 17 zilizopita
Novo Nordisk shares technical analysis: Buyer support underpins upward price move
Foreign Policy Journal
·
saa 23 zilizopita
Novo Nordisk (NYSE: NVO) Stock Price May Be 63% Undervalued As Buyback And Pipeline Catalysts Mount
TradingKey
·
siku 1 iliyopita
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Wasifu
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Kuhusu NOVOB80 KTB DR
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com